Avantor, Inc. (AVTR) stock
AVTRNYSELaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 10/3018% below fair value
$15.54−0.08 (-0.51%)
Close on Nov 13, 2026Market cap $10.53BP/E 31.1Yield –
Avantor EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Avantor's EPS for the twelve months ending Sep 30, 2026 was $0.50. For fiscal 2025 it was -$0.78, down 175.0% from the year before. The highest annual figure on record is $1.04 in fiscal 2024.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$0.78 | -175.0% |
| FY2024 | Dec 31, 2024 | $1.04 | +121.3% |
| FY2023 | Dec 31, 2023 | $0.47 | -53.5% |
| FY2022 | Dec 31, 2022 | $1.01 | +18.8% |
| FY2021 | Dec 31, 2021 | $0.85 | +844.4% |
| FY2020 | Dec 31, 2020 | $0.09 | – |
| FY2019 | Dec 31, 2019 | -$0.84 | – |
| FY2018 | Dec 31, 2018 | -$2.69 | – |
| FY2017 | Dec 31, 2017 | -$2.75 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $0.30 | – |
| Q2 FY2026 | Jun 30, 2026 | $0.06 | -33.3% |
| Q1 FY2026 | Mar 31, 2026 | $0.06 | -33.3% |
| Q4 FY2025 | Dec 31, 2025 | $0.08 | -89.0% |
| Q3 FY2025 | Sep 30, 2025 | -$1.04 | -1400.0% |
| Q2 FY2025 | Jun 30, 2025 | $0.09 | -35.7% |
| Q1 FY2025 | Mar 31, 2025 | $0.09 | 0.0% |
| Q4 FY2024 | Dec 31, 2024 | $0.73 | +386.7% |
| Q3 FY2024 | Sep 30, 2024 | $0.08 | -50.0% |
| Q2 FY2024 | Jun 30, 2024 | $0.14 | – |
| Q1 FY2024 | Mar 31, 2024 | $0.09 | -50.0% |
| Q4 FY2023 | Dec 31, 2023 | $0.15 | -28.6% |
| Q3 FY2023 | Sep 30, 2023 | $0.16 | -36.0% |
| Q2 FY2023 | Jun 30, 2023 | -$0.01 | -103.6% |
| Q1 FY2023 | Mar 31, 2023 | $0.18 | -35.7% |
| Q4 FY2022 | Dec 31, 2022 | $0.21 | +61.5% |
| Q3 FY2022 | Sep 30, 2022 | $0.25 | +4.2% |
| Q2 FY2022 | Jun 30, 2022 | $0.28 | +16.7% |
| Q1 FY2022 | Mar 31, 2022 | $0.28 | +12.0% |
| Q4 FY2021 | Dec 31, 2021 | $0.13 | +116.7% |
| Q3 FY2021 | Sep 30, 2021 | $0.24 | – |
| Q2 FY2021 | Jun 30, 2021 | $0.24 | +200.0% |
| Q1 FY2021 | Mar 31, 2021 | $0.25 | +400.0% |
| Q4 FY2020 | Dec 31, 2020 | $0.06 | -33.3% |
| Q3 FY2020 | Sep 30, 2020 | -$0.10 | -1100.0% |
| Q2 FY2020 | Jun 30, 2020 | $0.08 | – |
| Q1 FY2020 | Mar 31, 2020 | $0.05 | – |
| Q4 FY2019 | Dec 31, 2019 | $0.09 | – |
| Q3 FY2019 | Sep 30, 2019 | $0.01 | – |
| Q2 FY2019 | Jun 30, 2019 | -$0.98 | – |
| Q1 FY2019 | Mar 31, 2019 | -$0.59 | – |
| Q4 FY2018 | Dec 31, 2018 | -$0.94 | – |
| Q3 FY2018 | Sep 30, 2018 | -$0.26 | – |
| Q2 FY2018 | Jun 30, 2018 | -$0.70 | – |
| Q1 FY2018 | Mar 31, 2018 | -$0.79 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?